Portfolio news 0

Circassia plc

Preliminary Results For The Year Ended 31 December 2018

WaveOptics Ltd

The Duke of York opens WaveOptics new state of the art, purpose built head office

Athenex, Inc.

Cell Medica collaborators, Baylor College of Medicine and Texas Children’s Hospital, present positive early patient data from CAR-NKT neuroblastoma trial at American Society of Gene & Cell Therapy 22nd Annual Meeting

Xeros Technology Group plc

Year end results

Mirriad Advertising Ltd

John Pearson to succeed Roger Faxon as Chairman of Mirriad as strategic refocus gathers pace

Xeros Technology Group plc

Domestic and Commercial Laundry agreement secured with leading Indian OEM

Oxford Nanopore Technologies Plc

GrandOmics collaborates with Oxford Nanopore to deliver dbSV-100k, a project to deliver 100,000 affordable nanopore long-read human genomes

Inivata Limited

Positive results for prospective study in first-line metastatic NSCLC patients comparing InVisionFirst™-Lung to tissue comprehensive genomic profiling

IXICO

Trading update for the first half of financial year ending 31 March 2019

Diurnal Ltd

Alkindi® granted Orphan Drug Designation in Australia and grant of second Alkindi® patent in Australia